Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
BioSpace
https://www.biospace.com/article/anthos-therapeutics-is-developing-a-hemostasis-sparing-anticoagulant-to-reduce-the-hazard-of-bleeding/